Fifteen hypotensive patients were studied of whom only seven could be classified as having idiopathic orthostatic (postural) hypotension. These seven patients showed a marked decrease in their urinary output of the sympathetic neurohormone, noradrenaline. Furthermore, the rate of metabolism of circulating noradrenaline was somewhat less than normal; however, there was no significant alteration in noradrenaline metabolites. One patient, on whom autopsy was performed, showed degeneration of the sympathetic ganglia and nerves. Although there was infiltration with amyloid in these areas, it was not certain that amyloidosis was the primary disease. Nevertheless, there was an anatomic loss of the neurogenic structures involved in the synthesis of noradrenaline, which could explain the subnormal output of noradrenaline. Whereas, these results do not permit a definite conclusion that in idiopathic orthostatic hypotension there is an anatomic deficit or a decrease in efferent sympathetic neurons, nevertheless, evidence is presented which would seem to indicate this as the probable etiology.
SINCE the description of orthostatic hypotension by Bradbury and Eggleston' many reports2-11 and several reviews12-14 have been published on this subject. The causes of orthostatic hypotension are numerous; many are related to other diseases such as diabetes mellitus and neurological diseases, but particularly perplexing has been that group of patients having orthostatic hypotension without apparent underlying cause. In these patients there is functional alteration in the sympathetic nervous system that is manifested by inadequate arteriolar constriction, anhidrosis, sexual impotence, fixed heart rate, and often loss of bladder function, and diarrhea; the latter is probably related to para-changes in orthostatic hypotension, and Goodall and associates18 related the hypotension resulting from wightlessness to decreased sympathetic nerve activity.
The pathogenesis of the decreased noradrenaline output remains obscure. However, such decrease could result from a defect in the biosynthesis of noradrenaline, a decrease in its release, or an aberration in noradrenaline metabolism. The purpose of these experiments was to evaluate orthostatic hypotension in terms of release and metabolism of the sympathetic neurohormone.
Methods
Fifteen hypotensive patients were studied. Of this number, only seven could be classified as having idiopathic orthostatic (postural) hypotension. The other eight did not fall into this category since they had either an associated disease of the nervous system, that is, diabetic neuropathy, tabes, or syringomyelia, or had other known causes for their hypotension unrelated to the nervous system. Some of the patients were studied at the Clinical Research Center, Medical College of Virginia (FR 0065), and others were studied in their local hospitals. Each patient remained at sedentary activity or rest in bed. All medications were discontinued for at least 2 days prior to this study. Renal function of each patient was evaluated and found to be normal. Table 1 is a summary of the clinical findings of each patient with orthostatic hypotension in whom the metabolism of noradrenaline was studied.
Bioassay of Urine for Noradrenaline
One or more 24-hour urine samples were obtained from each of the patients and bioassayed for noradrenaline and adrenaline. The bioassay, although less sensitive than most fluorometric methods, was used in these experiments because of its specificity; it measures the biological activity of the natural-occurring isomers of noradrenaline and adrenaline.
Preparation of the urine extract was in accordance with the procedure adopted from von Euler and Hellner'9 and has been used by other investigators.18' 20 In brief, the urine was hydrolyzed and the adrenaline and noradrenaline were selectively adsorbed on aluminum hydrox- ide and filtered. The precipitate was washed and redissolved with 2 N H2SO4. The remaining salts were precipitated by mixing the extract with alcohol-acetone and filtered. The filtrate which contained the adrenaline and noradrenaline was concentrated in vacuo and tested on the cat's blood pressure which is sensitive to noradrenaline and on the hen's rectal cecum which is sensitive to adrenaline. Having determined the activity ratio for adrenaline and noradrenaline on the cat's blood pressure and on the hen's rectal cecum and the activity of the patient's urinary extract in terms of l-noradrenaline, the relative amounts of adrenaline and noradrenaline in the urine were calculated.'19 20
Metabolism of Noradrenaline
Five of the seven subjects who had idiopathic orthostatic hypotension were given 9.5 luc (80 ugg) of dl-noradrenaline 2-14C* (S.A. 20 mc/ mmole) (table 1). The purity of the injected dose as determined by column and paper chromatography was found to be at least 95%. The labeled noradrenaline was mixed with 10 ml of distilled water and injected into the antecubital vein over a period of 1 minute. Urine was collected by means of an indwelling catheter (Foley) at 10-minute intervals for 70 minutes, hourly for the next 5 hours, and a singl.e collection was made during the subsequent 18 hours for a total of 24 hours. The urine specimens were immediately frozen and stored at -20 C until assayed. Procedures for the separation and quantitation of the urinary catabolites of noradrenaline and *Volk-Radio-Chemical Company, Chicago, Illinois. Section of symiipathetic nerve. Deposits of amnyloid acre present within the nerve cauising disruption anid replacement of nerve fibers. Heizatoxylil and eosin, X 220.
adrenalinle in normal subjects have been previously described.2 22 In brief, an aliquot of urine containing 100,000 to 150,000 dpm was placed on a 1 x 5 cm column of Amberlite IRC-50 resin.* The column was washed with 30 ml of water. The effluent and wash were combined and saved. The Amberlite column was then eluted with 40 ml of 0.5 N acetic acid.
The column effluent (wash) anid eluate were each assayed for total radlioactivity as follows. Into each of two 20-ml counting vials xvas placed 1.0 ml of sample, to which was added 15.0 ml of previously prepared liquid fluor containing 15 g of naphthalene, 50 mg of POPOP, 2 g of PPO, 500 ml of absolute ethaniol, and 500 ml of reagent toluene. This was counted for 20 minutes, using a Packard automatic liquid scintillation spectrometer.
An aliquot of the eluate, containing 500 dpm, was evaporated to abouit I ml and cbromato-*CG-50, type II, Rohn & Hass Co., Philadelphia, Pennsylvania.
Crculation, Volumze XXXVI, October 1967 graphed for 24 hours on Whatman no. 1 paper; n-butanol saturated with N HCL was used as the solvent. After drying, the paper was cut into 1cm strips. Each strip was placed in a 20-ml counting vial filled with scintillation liquid, and its radioactivity was measured with a Tri-Carb Liquid Scintillation Spectrometer. Three radioactive peaks were obtained, corresponding to noradrenialine, normetadrenaline, and an unknown compound. Tbe percentage of radioactive noradrenaline, normetadrenaline, and the unknown substance in each sample was calculated, and wheni interpreted in terms of the total radioactivity recovered in the eluate of the Amberlite coluimn, gave information as to the total amount of radioactivity of each compound. An aliquot of the IRC-50 effluent containing 70,000 to 80,000 dpm was placed on a 0.9 x 45cm Dowex-l-acetate column (200 to 400 mesh).t The column was placed on an automatic fraction collector and attached to an automatic gradient t-Calhiochein, Los Angeles, California. rwF Figure 2 Sectiotn of sympathetic ganglon. Aoiiyloid deposits (the (lar-k miiaterial) wcere scattered throughout the gaunglia replacing ganglion cells. Ltuxol-fast blte staini, x 550. 
Results

Urinary Output of Noradrenaline
Of the 15 patients evaluated, seven showed all of the signs and symptoms of idiopathic orthostatic hypotension. These same seven subjects demonstrated a marked decrease in the 24-hour urinary output of noradrenaline (table 2); the adrenaline output was normal. Patients with orthostatic hypotension related to other diseases had normal to slightly elevated levels of urinary noradrenaline and adrenaline.
Noradrenaline Metabolism
Five of these seven patients were injected with labeled noradrenaline to evaluate their capacity to metabolize this sympathetic neurohormone. Results of these studies are summarized in tables 3 and 4. From these results, it appears that the rate of metabolism of noradrenaline was somewhat less than normal, since at 70 minutes, 6 hours, and 24 hours after injection less radioactivity was recovered in these subjects than in normal subjects during similar periods (table 3) . This difference, however, was not sufficiently great to permit a definite conclusion of altered metabolism. Further, it would appear that there was a slight decrease in the amount of normetadrenaline glucuronic acid conjugate (NMC II) and 3, 4-dihydroxyphenylglycol sulfate (DOPEG SO4) (table 4) but again the difference is Qnot sufficiently great to conclude that there was any significant alteration in these metabolites. Thus, in subjects with orthostatic hypoteision, the metabolism of circulating noradrernaline, although slightly delayed, did not differ greatly from that in normal subjects.
Dliscussion
It is generally accepted that noradrenaline is the neurohormone of the sympathetic nerves23-25 and has a fundamental role in Circulation, Volume XXXVI, October 1967 the regulation of vascular tone.25-31 Therefore, any decrease in sympathetic nerve activity as it relates to the vascular bed would result in a decrease in vascular tone. These results (table 2) and those of other investigators15-17 show that in this form of orthostatic hypotension the amount of circulating or urinary noradrenaline or both decreases. Such a deficit could result from accelerated metabolism, or decrease in release, or a defect in the biosynthesis of this neurohormone. However, the results of these experiments indicate that patients with idiopathic orthostatic hypotension metabolize circulating noradrenaline somewhat more slowly than normal subjects (tables 3 and 4), and this militates against the possibility of accelerated metabolism. Therefore, it would seem reasonable to conclude that the defect in idiopathic orthostatic hypotension is not related to any defect in the metabolism of circulating noradrenaline. Nevertheless, the amount of noradrenaline recovered in the urine of these subjects was markedly reduced (table 2), suggesting that the pathogenesis involves either a biosynthetic defect or a subnormal release, an alteration in metabolism of endogenous noradrenaline as it is released at the nerve endings, or some combination of these.
The available data suggest that there may be an anatomic deficit of efferent sympathetic neurons which would explain the decrease in noradrenaline output and, at the same time, would be compatible with the delay in metabolism. The only subject, M.Q., on whom anatomic observations were available had degeneration of autonomic ganglia, primarily sympathetic ganglia, and the preganglionic nerves (figs. 1 and 2). Amyloidosis was apparently the primary disease and in many areas there was infiltration around the blood vessels. Nevertheless, the anatomic loss of the neurogenic structures involved in the synthesis of noradrenaline was the most prominent finding and this could explain the subnormal output of noradrenaline (table 2). The concept of loss of neurogenic structures,32 34 either due to amyloidosis35 or to other diseases, has been 
